AbbVie (ABBV) Debt Ratio (2012 - 2026)

AbbVie (ABBV) reported Debt Ratio of 0.47 for Q1 2026, down 5.72% year-over-year from 0.5 in Q1 2025, and up 3.11% quarter-over-quarter from 0.46 in Q4 2025.

AbbVie (ABBV) Debt Ratio (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has 15 years of Debt Ratio data on file, last reported at 0.47 in Q1 2026.

  • Debt Ratio for Q1 2026 came in at 0.47, down 5.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.47 (down 5.72% YoY), and the FY2025 annual result was 0.46, down 7.67% from the prior year.
  • Debt Ratio improved to 0.47 in Q1 2026 per ABBV's latest filing, from 0.46 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.51 in Q2 2022 and troughed at 0.41 in Q2 2023.
  • A 5-year average of 0.47 and a median of 0.46 in 2023 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2022 and 2024: Debt Ratio dropped 21.93% in 2022, then climbed 20.7% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.46 in 2022, then decreased by 3.29% to 0.44 in 2023, then advanced by 12.69% to 0.5 in 2024, then slipped by 7.67% to 0.46 in 2025, then rose by 3.11% to 0.47 in 2026.
  • Business Quant data shows ABBV's Debt Ratio at 0.47 in Q1 2026, 0.46 in Q4 2025, and 0.49 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -0.22
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.37
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 0.27
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.47
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.38
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.62
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.39
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 0.31
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 0.51
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.47
Dec 31, 2025 0.46
Sep 30, 2025 0.49
Jun 30, 2025 0.47
Mar 31, 2025 0.50
Dec 31, 2024 0.50
Sep 30, 2024 0.50
Jun 30, 2024 0.50
Mar 31, 2024 0.43
Dec 31, 2023 0.44
Sep 30, 2023 0.45
Jun 30, 2023 0.41
Mar 31, 2023 0.46
Dec 31, 2022 0.46
Sep 30, 2022 0.43
Jun 30, 2022 0.51
Mar 31, 2022 0.44
Dec 31, 2021 0.52
Sep 30, 2021 0.54
Jun 30, 2021 0.55